AN2 Therapeutics Inc.
(ANTX) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
1.38
-0.36%
After-hours Jan 06, 2025, 04:51 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
PE Ratio | -7.47 | -4.46 | -13.44 | -21.22 | -51.21 |
PS Ratio | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 3.88 | 1.94 | -6.09 | -14.2 | 59.96 |
P/FCF Ratio | -9.07 | -5.53 | -14.09 | -53.8 | -116.09 |
P/OCF Ratio | -9.07 | -5.53 | -14.09 | -53.8 | -116.09 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | 0.00 | n/a | n/a | 0.15 |
Quick Ratio | 7.87 | 13.72 | 17.70 | 2.90 | 35.85 |
Current Ratio | 7.87 | 13.72 | 17.70 | 2.90 | 35.85 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -82.22 | n/a | n/a | n/a |
Return on Equity (ROE) | -0.52 | -0.43 | 0.45 | 0.67 | -1.17 |
Return on Assets (ROA) | -0.47 | -0.4 | -0.33 | -3.21 | -0.99 |
Return on Capital (ROIC) | -0.56 | -0.44 | -0.35 | -2.62 | -0.93 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a |